A new bowel scoring tool to evaluate Crohn’s disease is reliable, easy to use, and ready for clinicians to put into practice, according to study.

A team looks at how a more intentional approach to care can benefit individuals with the gastroenterological condition.

Gastrointestinal experts explore the benefits of the drug when treating patients with acute severe ulcerative colitis.

Study in people taking a biologic drug for autoimmune diseases shows association of patient support programs with reduced chance of starting opioid pain medicines or continuing on them.

Studies suggest the gut microbiome can influence immunotherapy side effects. Butyrate emerges as an intriguing candidate against inflammation in the colon.

Simplified scoring tool accurately measures inflammation and healing in the gut for children with Crohn’s disease, a type of inflammatory bowel disease.